EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280–acetylated tau in cell and mouse models

Ha-Lim Song, Na-Young Kim, Jaewan Park, Meong Il Kim, Yu-Na Jeon, Se-Jong Lee, Kwangmin Cho, Young-Lim Shim, Kyoung-Hye Lee, Yeon-Seon Mun, Jung-A Song, Min-Seok Kim und 7 weitere

Journal of Clinical Investigation · 2023

DOI: 10.1172/jci156537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Ha-Lim Song und 18 weiteren Autor:innen. Beteiligte Einrichtung: ADEL Institute of Science & Technology (AIST), ADEL Inc., Seoul, South Korea. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Tauopathies, Alzheimer Disease. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, ICT, and Future Planning, Ministry of Health & Welfare, Republic of Korea, Korean government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesTauopathiesAlzheimer DiseaseMiceAnimalsAntibodies, Monoclonaltau ProteinsLysineDisease Models, AnimalBrain

Stichwörter der Autor:innen

Alzheimer diseaseImmunotherapyNeuroscienceTherapeutics

Substanzen

Antibodies, Monoclonaltau ProteinsLysine

Autor:innen und Institutionen

  • ADEL Institute of Science & Technology (AIST), ADEL Inc., Seoul, South Korea.
  • Division of Biological Science and Technology, Yonsei University, Wonju, South Korea.
  • Department of Brain Science and.
  • Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Neural Circuits Research Group, Korea Brain Research Institute, Daegu, South Korea.
  • Samsung Alzheimer's Convergence Research Center, Department of Neurology, Neuroscience Center, Samsung Medical Center, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University School of Med…

Förderung

  • Ministry of Science, ICT, and Future Planning
  • Ministry of Health & Welfare, Republic of Korea
  • Korean government

Zitieren

APA

Song, H. L., Kim, N. Y., Park, J., Kim, M. I., Jeon, Y. N., Lee, S. J., Cho, K., Shim, Y. L., Lee, K. H., Mun, Y. S., Song, J. A., Kim, M. S., Pack, C. G., Jung, M., Jang, H., Na, D. L., Hong, M., Kim, D. H., & Yoon, S. Y. (2023). Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280–acetylated tau in cell and mouse models. Journal of Clinical Investigation. https://doi.org/10.1172/jci156537

Vancouver

Song HL, Kim NY, Park J, Kim MI, Jeon YN, Lee SJ, et al. Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280–acetylated tau in cell and mouse models. Journal of Clinical Investigation. 2023. doi:10.1172/jci156537

BibTeX
@article{Song2023,
  author = {Song, Ha-Lim and Kim, Na-Young and Park, Jaewan and Kim, Meong Il and Jeon, Yu-Na and Lee, Se-Jong and Cho, Kwangmin and Shim, Young-Lim and Lee, Kyoung-Hye and Mun, Yeon-Seon and Song, Jung-A and Kim, Min-Seok and Pack, Chan-Gi and Jung, Minkyo and Jang, Hyemin and Na, Duk L and Hong, Minsun and Kim, Dong-Hou and Yoon, Seung-Yong},
  title = {Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280–acetylated tau in cell and mouse models},
  journal = {Journal of Clinical Investigation},
  year = {2023},
  doi = {10.1172/jci156537}
}
Kostenlos starten →